Prentiss Smith & Co’s Accendra Health ACH Stock Holding History

Prentiss Smith & Co’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,375	Closed	-$56K	–	177
2018 Q3	$56K	Hold	3,375	–	–	0.03%	108
2018 Q2	$56K	Hold	3,375	–	–	0.03%	109
2018 Q1	$52K	Buy	+3,375	New	+$60.2K	0.03%	123
2017 Q4	–	Sell	-3,375	Closed	-$99K	–	318
2017 Q3	$99K	Buy	+3,375	New	+$99.7K	0.06%	85

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Prentiss Smith & Co's ACH Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Accendra Health (ACH) in Q4 2018, closing a stake of 3,375 shares — an estimated $56K sold.

Prentiss Smith & Co first reported a position in ACH in Q3 2017 and held it in 4 quarters. The position peaked at $99K in Q3 2017. 210 funds tracked by Wall St. Rank hold ACH as of Q4 2018.

Prentiss Smith & Co reported no remaining Accendra Health position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 3,375 Accendra Health shares in Q4 2018, an estimated $56K.
Prentiss Smith & Co first reported a position in Accendra Health in Q3 2017 and held it in 4 quarters.
Prentiss Smith & Co's Accendra Health position peaked at $99K in Q3 2017.
210 funds tracked by Wall St. Rank held Accendra Health as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.